Modulation of Cytotoxicity of Benzamide Riboside by Expression of NMN Adenylyltransferase
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
749-758
Author(s):
Joel A. Yalowitz and Hiremagalur N. Jayaram
Antitumor Activity of Benzamide Riboside In Vitro and In Vivo
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
773-779
Author(s):
Ladislav Novotny, Peter Rauko, Joel A. Yalowitz and Thomas Szekeres
Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
781-786
Author(s):
Walter Jager, Alexandra Salamon and Thomas Szekeres
Biomolecular Targets for Platinum Antitumor Drugs
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
103-111
Author(s):
Rathindra N. Bose
Bisphosphonates-Anti-Inflammatory Properties
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
15-28
Author(s):
Walter P. Maksymowych
Subject Index To Volume 1
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
105-105
Author(s):
Science Publishers Bentham and Bentham Science Publishers
Recent Advances in Antiplatelet Agents
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
577-589
Author(s):
Jean-Michel Dogne, Xavier de Leval, Patricia Benoit, Jacques Delarge, Bernard Masereel and Jean-Louis David
Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
1-17
Author(s):
sheila A. Stewart and William C. Hahn
Diphtheria Fusion Protein Therapy of Chemoresistant Malignancies
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
19-36
Author(s):
Arthur E. Frankel, Patrick Rossi, Timothy M. Kuzel and Francine Foss
Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
37-43
Author(s):
Jason S. Damiano